Notable Labs, Ltd. (NTBLQ)

OTCMKTS · Delayed Price · Currency is USD
0.160
+0.010 (6.67%)
Oct 30, 2024, 4:00 PM EDT
-94.10%
Market Cap 1.55M
Revenue (ttm) 313.00K
Net Income (ttm) -10.54M
Shares Out 9.66M
EPS (ttm) -1.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 130,600
Open 0.120
Previous Close 0.150
Day's Range 0.120 - 0.160
52-Week Range 0.100 - 4.240
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Notable Labs

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company’s pipeline includes... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 16
Stock Exchange OTCMKTS
Ticker Symbol NTBLQ
Full Company Profile

Financial Performance

In 2023, Notable Labs's revenue was $310,000, an increase of 3775.00% compared to the previous year's $8,000. Losses were -$11.26 million, -21.82% less than in 2022.

Financial Statements

News

There is no news available yet.